Výsledky vyhledávání

Abstract P5-13-11: Patient characteristics and treatment patterns by BRCA/ATM mutation status in patients with metastatic triple-negative breast cancer in the US: An electronic health records (EHR) based study

Autor: Gboyega Adeboyeje, Maria Sierra, Amy Bartels, Michelle Field, Sumit Jhamb, Ami Buikema, Seongjung Joo

Publikováno v: Cancer Research. 82:P5-13

Background: Mutational testing of genes involved in DNA damage repair can help identify patients with metastatic triple-negative breast cancer (mTNBC) who might derive clinical benefit from poly (ADP-ribose) polymerase (PARP) inhibitors. We examined

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a72a4da22b272c8f4b3dbcb22ed4def
https://doi.org/10.1158/1538-7445.sabcs21-p5-13-11

Zobrazit plný text záznamu

Abstract P2-08-21: Overall survival associated with BRCA or ATM mutation status in patients with metastatic triple-negative breast cancer: Findings from the PRIOR-2 study

Autor: Gboyega Adeboyeje, Maria Sierra, Amy Bartels, Michelle Field, Sumit Jhamb, Ami Buikema, Seongjung Joo

Publikováno v: Cancer Research. 82:P2-08

Background: Many clinical guidelines recommend patients with metastatic triple-negative breast cancer (mTNBC) undergo mutational testing of genes involved in DNA damage repair response as a predictive marker of clinical benefit from recently approved

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b39fac36db4f8181f8b544d9a1d2d39
https://doi.org/10.1158/1538-7445.sabcs21-p2-08-21

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání